Home-Based Infant Behavior Intervention for Behavioral Problems
(PANTHERS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to evaluate the effectiveness of a remote home-based program in reducing behavior problems in infants from high-risk families. Participants will receive either the Infant Behavior Program (IBP), which enhances parent-infant interaction, or Enhanced Pediatric Primary Care (EPPC), which educates on key developmental and health topics. Both treatments are delivered through remote sessions. Families with infants aged 12 to 18 months who exhibit noticeable behavior issues and have an English or Spanish-speaking caregiver may be suitable for this trial. As an unphased trial, this study offers families the chance to contribute to innovative research that could improve early childhood development strategies.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that the Infant Behavior Program (IBP) is safe and well-received. This program, a home-based version of Parent-Child Interaction Therapy (PCIT), effectively addresses children's behavior issues. Importantly, no major reports of negative effects have emerged from this treatment. Thus, the IBP is safe for families seeking to address early behavior problems in infants.12345
Why are researchers excited about this trial?
Researchers are excited about the Infant Behavior Program (IBP) because it offers a novel home-based approach specifically tailored for infants, addressing their unique developmental needs. Unlike traditional methods that often require in-person sessions, IBP can be completed entirely remotely, making it more accessible for families. This approach adapts the evidence-based Child-Directed Interaction phase of Parent-Child Interaction Therapy, which is already known for effectively managing early behavioral problems. By maintaining the core features of this proven therapy and adapting it for infants, IBP holds promise for early intervention in a convenient, family-centered manner.
What evidence suggests that this trial's treatments could be effective for decreasing behavior problems in infants?
Research has shown that the Infant Behavior Program (IBP), a treatment in this trial, can help reduce behavior problems in babies. Specifically, studies found that babies participating in the IBP demonstrated better self-control after the program. At a 6-month follow-up, these babies also listened to their parents more and had fewer outbursts, such as tantrums. The program shows promise for improving behaviors in both babies and parents. The IBP is based on Parent-Child Interaction Therapy but is specially adjusted for babies' needs.26789
Who Is on the Research Team?
Daniel M Bagner, PhD
Principal Investigator
Florida International University
Are You a Good Fit for This Trial?
The PANTHERS Project is for infants aged 12 to 18 months with behavior problems and their primary caretakers, who must be at least 18 years old. Caretakers should speak English or Spanish and have no significant cognitive delays. Families involved with child protection services or infants with major sensory impairments or severe mobility issues cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive six remote treatment sessions of either the Infant Behavior Program (IBP) or the Enhanced Pediatric Primary Care (EPPC) program
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Enhanced Pediatric Primary Care (EPPC)
- Infant Behavior Program (IBP)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Florida International University
Lead Sponsor
Nicklaus Children's Hospital f/k/a Miami Children's Hospital
Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator